BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25897339)

  • 1. Effect of PEG pairing on the efficiency of cancer-targeting liposomes.
    Saw PE; Park J; Lee E; Ahn S; Lee J; Kim H; Kim J; Choi M; Farokhzad OC; Jon S
    Theranostics; 2015; 5(7):746-54. PubMed ID: 25897339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
    Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
    J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.
    Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S
    J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
    Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
    Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
    Qhattal HS; Hye T; Alali A; Liu X
    ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
    Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.
    Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M
    J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
    Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
    Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.
    Mohammadgholi M; Sadeghzadeh N; Erfani M; Abediankenari S; Abedi SM; Emrarian I; Jafari N; Behzadi R
    Anticancer Agents Med Chem; 2018; 18(2):277-285. PubMed ID: 28925879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
    Li WM; Mayer LD; Bally MB
    J Pharmacol Exp Ther; 2002 Mar; 300(3):976-83. PubMed ID: 11861806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
    Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
    Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma.
    Saw PE; Xu X; Kang BR; Lee J; Lee YS; Kim C; Kim H; Kang SH; Na YJ; Moon HJ; Kim JH; Park YK; Yoon W; Kim JH; Kwon TH; Choi C; Jon S; Chong K
    Theranostics; 2021; 11(2):941-957. PubMed ID: 33391514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
    Garg A; Tisdale AW; Haidari E; Kokkoli E
    Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
    Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
    Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer.
    Suga T; Fuchigami Y; Hagimori M; Kawakami S
    Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
    Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
    Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.